The Federal Trade Commission released a second interim report showing that the three largest pharmacy benefit managers — CVS Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — marked up ...

The author says CVS’s growth has come at a significant cost to patients, local pharmacies, taxpayers and fair competition.

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called pharmacy middlemen are partially to blame. A handful of pharmacy benefit ...

CVS Caremark last week agreed to pay $5 million to consumers to settle a Federal Trade Commission investigation into its marketing of the prices of certain drugs. Following the 2007 acquisition of ...

CVS Health on Tuesday said it will revamp how it prices prescription drugs and scrap a complex model that typically sets how much pharmacies get reimbursed and what patients pay for those medications.

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive.

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.

CVS Health, UnitedHealth Group and Cigna are suing the FTC, claiming that the agency's case against drug supply chain middlemen over high insulin prices in the U.S. is unconstitutional. The complaint ...

President-elect Donald Trump criticized pharmacy benefit managers, calling them “rich as hell” and accused them of being responsible for raising drug prices at a Monday press conference. Shares of ...